(firstQuint)Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers.

 This is a single-center, open-label, randomized, 4-period crossover study of the pharmacokinetics of a new formulation of deferiprone, delayed release tablets in twenty healthy volunteers.

 In each study period, blood samples for pharmacokinetics assessment will be collected pre-dose and over 24 hours post-dose.

 Safety will be assessed throughout the study.

.

 Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers@highlight

The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone delayed release tablets) under fed and fasting conditions.

